Literature DB >> 28479363

Circadian Clock Is Involved in Regulation of Hepatobiliary Transport Mediated by Multidrug Resistance-Associated Protein 2.

Ju-Hee Oh1, Joo Hyun Lee1, Dong-Hee Han2, Sehyung Cho2, Young-Joo Lee3.   

Abstract

There has been a growing interest in circadian regulation of the expression and function of drug transporters. In this study, we investigated circadian rhythm in the expression and function of multidrug resistance-associated protein 2 (Mrp2) in mouse liver and involvement of circadian clock in their regulations by using the circadian clock genes (period 1 and period 2) knockout mice. The mRNA and protein expression of Mrp2, P-glycoprotein, and breast cancer resistance protein was measured in the mouse liver at different times of the day. Circadian variation of hepatobiliary excretion of phenolsulfonphthalein, a model substrate of Mrp2, was also investigated in mice. Circadian oscillation of Mrp2 protein expression was clearly observed in the mouse liver with levels down at the light phase and up at the dark phase. The cumulative biliary excretion and biliary clearance of phenolsulfonphthalein from the liver to the bile was 2.37- and 1.74-fold greater in mice administered during the dark phase than in those administered during the light phase, respectively. The circadian oscillation in mRNA expression of Mrp2 disappeared in period 1 and period 2 double knockout mice. These results suggest that the expression and function of Mrp2 show the circadian rhythm, controlled by circadian clock genes.
Copyright © 2017 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABC transporters; P-glycoprotein; biliary excretion; multidrug resistance-associated proteins; pharmacokinetics

Mesh:

Substances:

Year:  2017        PMID: 28479363     DOI: 10.1016/j.xphs.2017.04.071

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  7 in total

Review 1.  Timing in drug absorption and disposition: The past, present, and future of chronopharmacokinetics.

Authors:  Joana Bicker; Gilberto Alves; Amílcar Falcão; Ana Fortuna
Journal:  Br J Pharmacol       Date:  2020-03-20       Impact factor: 8.739

Review 2.  Molecular Aspects of Circadian Pharmacology and Relevance for Cancer Chronotherapy.

Authors:  Narin Ozturk; Dilek Ozturk; Ibrahim Halil Kavakli; Alper Okyar
Journal:  Int J Mol Sci       Date:  2017-10-17       Impact factor: 5.923

3.  The Circadian Clock Gene Bmal1 Controls Intestinal Exporter MRP2 and Drug Disposition.

Authors:  Fangjun Yu; Tianpeng Zhang; Cui Zhou; Haiman Xu; Lianxia Guo; Min Chen; Baojian Wu
Journal:  Theranostics       Date:  2019-04-13       Impact factor: 11.556

4.  Bmal1 regulates circadian expression of cytochrome P450 3a11 and drug metabolism in mice.

Authors:  Yanke Lin; Shuai Wang; Ziyue Zhou; Lianxia Guo; Fangjun Yu; Baojian Wu
Journal:  Commun Biol       Date:  2019-10-16

5.  Circadian Clock Gene Bmal1 Regulates Bilirubin Detoxification: A Potential Mechanism of Feedback Control of Hyperbilirubinemia.

Authors:  Shuai Wang; Yanke Lin; Ziyue Zhou; Lu Gao; Zemin Yang; Feng Li; Baojian Wu
Journal:  Theranostics       Date:  2019-07-09       Impact factor: 11.556

6.  Evaluation of the Mrp2-mediated flavonoid-drug interaction potential of quercetin in rats and in vitro models.

Authors:  Ju-Hee Oh; Joo Hyun Lee; Young-Joo Lee
Journal:  Asian J Pharm Sci       Date:  2019-01-16       Impact factor: 6.598

7.  The Daily Expression of ABCC4 at the BCSFB Affects the Transport of Its Substrate Methotrexate.

Authors:  André Furtado; Rafael Mineiro; Ana Catarina Duarte; Isabel Gonçalves; Cecília R Santos; Telma Quintela
Journal:  Int J Mol Sci       Date:  2022-02-23       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.